NASDAQ: PCSA
Processa Pharmaceuticals Inc Earnings Dates, Reports, Calls

Processa Pharmaceuticals earnings were -$13.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PCSA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.3M, down 3.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PCSA reported annual earnings of -$13.6M, with 14.5% growth. The next PCSA earnings date is Nov 5, 2026.

PCSA earnings history

Current Revenue
$0.0
Current Earnings
-$13.4M
Current Profit Margin
0%

PCSA Return on Equity

Current Company
-394.2%
Current Industry
-13.6%
Current Market
31%
PCSA's Return on Equity (-394.2%)... subscribe to Premium to read more.
High Return on Equity Performance

PCSA Return on Assets

Current Company
-244.5%
Current Industry
-10.2%
PCSA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PCSA announces earnings.

PCSA Return on Capital Employed

Current Company
4,233.99%
Current Industry
-6.7%
PCSA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PCSA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PCSA-$13.41M-$13.44MN/A-$4.39
PULM-$4.01M-$4.03MN/A-$1.10
MLECN/AN/AN/A-$10.52
EVGN-$3.54M-$9.07MN/A-$0.96
CLGN-$12.25M-$13.13MN/A-$10.30

PCSA earnings dates

Next earnings date
Nov 5, 2026

Processa Pharmaceuticals Earnings Reports & History FAQ

What were Processa Pharmaceuticals's earnings last quarter?

On PCSA's earnings call on Aug 20, 2026, Processa Pharmaceuticals (NASDAQ: PCSA) reported Q2 2026 earnings per share (EPS) of -$1.19, up 80.99% year over year. Total PCSA earnings for the quarter were -$3.27 million. In the same quarter last year, Processa Pharmaceuticals's earnings per share (EPS) was -$6.26.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.

When does Processa Pharmaceuticals report earnings?

The next PCSA earnings call is Nov 5, 2026. Add PCSA to your watchlist to be reminded of Processa Pharmaceuticals's next earnings date.

What was PCSA's earnings growth in the past year?

As of Processa Pharmaceuticals's earnings date in Aug 20, 2026, Processa Pharmaceuticals's earnings has grown year over year. PCSA earnings in the past year totalled -$13.44 million.

Is Processa Pharmaceuticals profitable or losing money?

As of the last Processa Pharmaceuticals earnings report, Processa Pharmaceuticals is currently losing money. Processa Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$13.44 million, a 4.32% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.